Filtration induces changes in activity states and leucocyte populations

Transfusion and Apheresis Science

Volumn 28, Issue 3, 2003, Pages 319-327

  Trindade, H ^a,b   Carvalho, H ^b   Sousa, G ^a   Machado Caetano, J A ^b   Seghatchian, J ^c  

^a Ministerio da Saude Portuguese   (Portugal)

^b Serviço Imunologia F C M L   (Portugal)

^c Blood Components Technology Consultancy   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD20 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; THROMBOCYTE CONCENTRATE;

ANTIGEN DETECTION; ARTICLE; B LYMPHOCYTE; BIOLOGICAL MONITORING; BLOOD FILTRATION; BONE MARROW CELL; CELL ACTIVITY; CELL LOSS; CELL SUBPOPULATION; CELL SUSPENSION; CELL VIABILITY; CELLULAR DISTRIBUTION; ENRICHMENT CULTURE; FILTER; IMMUNOPHENOTYPING; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; METHODOLOGY; NEUTROPHIL; STATISTICAL ANALYSIS; STORAGE; T LYMPHOCYTE; THROMBOCYTE RICH PLASMA; UPREGULATION;

EID: 0037410199     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-0502(03)00052-1     Document Type: Article

References (15)

1. International forum. Universal leucocyte-depletion of blood components: cell concentrates and plasma. Vox Sang 2001;81:56-77.
2. Dzik S., AuBuchon J., Jeffries L., Kleinman S., Manno C., Murphy M.et al. Leucocyte reduction of blood components: public policy and new technology. Transfus. Med. Rev. 14:2000;34-52.
3. Bruce M.E., Will R.G., Ironside J.W., McConnell I., Drummond D., Suttie A.et al. Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature. 389:1997;498-501.
4. Hill A.F., Desbruslais M., Joiner S., Sidle K.C.L., Gowland I., Doey L.J.et al. The same prion strain causes vCJD and BSE. Nature. 389:1997;448-450.
5. Klein M.A., Frigg R., Flechsig E., Raeber A.J., Kalinke U., Bluethmann H.et al. A crucial role for B cells in neuroinvasive scrapie. Nature. 390:1997;687-690.
6. Murphy M.F. New variant Creutzfeldt-Jacob Disease (nvCJD): the risk of transmission by blood transfusion and the potential benefit of leucocyte reduction of blood components. Transfus. Med. Rev. 13:1999;75-83.
7. Sowemimo-Coker S.O., Kirn A., Tribble E., Brandwein H.J., Wenz B. White cell subsets in apheresis and filtered platelet concentrates. Transfusion. 38:1998;650-657.
8. Seghatchian J., Krailadsiri P. Validation of different enrichment strategies for analysis of leucocyte sub-population: development and application of a new approach, based on leucofiltration. Transfus. Apher. Sci. 26:2002;61-72.
9. Rider J.R., Want E.J., Winter M.A., Turton J.R., Pamphilon D.H., Nobes P. Differential leucocyte subpopulation analysis of leucodepleted red cell products. Transf. Med. 10:2000;49-58.
10. Mascaretti L., Baggi L., Riva M., Proserpio P., Dassi M., Varallo F.et al. Lymphocyte subsets in inline packed red blood cell units: comparison between low and high spin procedures. Tranfus. Apher. Sci. 26:2002;167-174.
11. Triulzi D.J., Meyer E.M., Donnenberg A.D. WBC subsets analysis of WBC-reduced platelet concentrates. Transfusion. 40:2000;771-780.
12. Barclay G.R., Walker B., Gibson J., McColl K., Turner M.L. Quality assurance by a commercial flow cytometry method of leucodepletion of whole blood donations: initial application of universal testing and proposals for a batch-release sampling plan. Transf. Med. 10:2000;37-48.
13. Steneker I., Beiwenga J. Histologic and immunohistochemical studies on the preparation of white cell-poor red cell concentrates: the filtration process using three different polyester filters. Transfusion. 31:1991;40-46.
14. Sivakumaran M., Saunders P., Hanmer D., Drury M., Seghatchian J. Leucocyte fragments in prestorage-leucodepleted blood products: a qualitative analysis. Transfus. Sci. 22:2000;81-82.
15. Seghatchian J., Krailadsiri P., Beard M., Bukasa A., Bashir S. Studies on the characterization of the cause of leucoreduction failures with particular reference to extra gatal events. Transfus. Apher. Sci. 26:2002;47-60.